Wajida Leclerc
Geen lopende functies
Oorsprong van het eerstegraads netwerk van Wajida Leclerc
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
QLT, Inc.
 QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada.
39
| Extinct | Miscellaneous Commercial Services | 39 |
British Columbia Lottery Corp.
 British Columbia Lottery Corp. Casinos/GamingConsumer Services British Columbia Lottery Corp. manages and owns casinos. The private company is based in Kamloops, Canada. Lynda Cavanaugh has been the CEO of the Canadian company since 2021.
6
| Extinct | Casinos/Gaming | 6 |
| Public Company | Pharmaceuticals: Major | 5 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Wajida Leclerc via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| University of British Columbia | College/University | Undergraduate Degree Masters Business Admin Corporate Officer/Principal Undergraduate Degree Undergraduate Degree Undergraduate Degree Doctorate Degree Graduate Degree Corporate Officer/Principal Undergraduate Degree Masters Business Admin | |
ImStar Therapeutics, Inc.
 ImStar Therapeutics, Inc. BiotechnologyHealth Technology ImStar Therapeutics, Inc. develops therapies for ALS and neurodegenerative disease. The firm's lead drug candidate is IMS-088, a small-molecule compound currently in preclinical development. It is studying compounds directed at a proprietary new therapeutic target for ALS called TANA. The company was founded by Daniel J. Wattier and Jean-Pierre Julien in 2012 and is headquartered in Vancouver, Canada. | Biotechnology | Founder Chairman Director/Board Member Founder | |
Axys Pharmaceuticals, Inc.
 Axys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Axys Pharmaceuticals, Inc. engages in the development of integrated drugs. The company is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Corporate Officer/Principal | |
| McGill University | College/University | Undergraduate Degree Undergraduate Degree Doctorate Degree | |
| ARBUTUS BIOPHARMA CORPORATION | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer General Counsel | |
Phoenix Molecular Designs Ltd.
 Phoenix Molecular Designs Ltd. Miscellaneous Commercial ServicesCommercial Services Phoenix Molecular Designs operates as a biopharmaceutical company. It focuses on developing first-in-class inhibitors against ribosomal S6 kinase (RSK), an important drug target for cancer, heart disease, and inflammation. The company was founded by Sandra Dunn in 2012 and is headquartered in Vancouver, Canada. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
| INMED PHARMACEUTICALS INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer General Counsel | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Chairman Corporate Officer/Principal | |
California Life Sciences Association
 California Life Sciences Association Miscellaneous Commercial ServicesCommercial Services California Life Sciences Association (CLSA) is the largest and most influential life sciences advocacy and business leadership organization in California. The non-profit company is based in South San Francisco, CA, and has offices in other locations as well. The company works closely with industry, government, academia, and others to shape public policy, improve access to innovative technologies, and grow California's life sciences economy. CLSA serves biotechnology, pharmaceutical, medical device, and diagnostics companies, research universities and institutes, investors, and service providers throughout the state. Mike Guerra has been the CEO of the company since 2019. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Chairman | |
LIB Therapeutics LLC
 LIB Therapeutics LLC Pharmaceuticals: MajorHealth Technology LIB Therapeutics LLC is a pharmaceutical company that manufactures medicinal products. The private company is based in Wilmington, DE. The company was founded by Evan A. Stein, August James Troendle. David A. Cory has been the CEO of the company since 2023. | Pharmaceuticals: Major | Founder Founder | |
Valocor Therapeutics, Inc.
 Valocor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Valocor Therapeutics is a clinical-stage, privately-held company dedicated to developing innovative treatments for major unmet needs in dermatology. The company's portfolio of dermatology therapeutics includes Lemuteporfin, a potent and selective topical photodynamic therapy for moderate to severe acne and a portfolio of novel, topical small molecule therapeutics targeting acne, sebaceous gland hyperactivity, skin pigmentation disorders and inflammatory skin diseases. Valocor Therapeutics is headquartered in Vancouver, British Columbia. Although many common yet serious skin conditions have unsatisfactory treatment options, dermatology has in recent years attracted limited research resources and investment. As a result, a sparse pipeline and a lack of true scientific innovation have been the dominant themes of this field for the last twenty years. During this same period, technological advances have produced new research techniques that have greatly expanded its ability to study disease processes and establish new effective therapeutic strategies. Much of this innovative research has been applied to the fields such as oncology, autoimmunity, and ocular diseases. Valocor is applying current biotechnology techniques to develop breakthrough therapies for major dermatological diseases, where prevalent conditions, minimal competition and important medical needs exist. | Pharmaceuticals: Major | Chief Executive Officer Chairman | |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
BIOTECanada
 BIOTECanada BiotechnologyHealth Technology BIOTECanada serves as a national association for Canada's health, industrial and agricultural biotechnology sectors. The company was founded in 1986 and is headquartered in Ottawa, Canada. | Biotechnology | Director/Board Member Director/Board Member | |
Genome British Columbia
 Genome British Columbia Miscellaneous Commercial ServicesCommercial Services Genome British Columbia invests in and manages genomics and proteomics research projects. It offers services in human health, environment, agriculture, forestry, mining, energy, aquaculture, and fisheries. The company was founded in 2000 and is headquartered in Vancouver, Canada. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| ONCOMED PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Renovis, Inc.
 Renovis, Inc. Pharmaceuticals: MajorHealth Technology Renovis, Inc. develops pharmaceutical products. The company discovers, develops, and commercializes novel therapeutics for neurological and inflammatory diseases. It is headquartered in San Francisco, CA | Pharmaceuticals: Major | Corporate Secretary Director/Board Member | |
| COHERUS BIOSCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
MedImmune Vaccines, Inc.
 MedImmune Vaccines, Inc. BiotechnologyHealth Technology MedImmune Vaccines, Inc. develops, manufactures and markets live vaccines. Its developed vaccine is inhaled FluMist. The company is located in Mountain View, CA | Biotechnology | Director/Board Member President | |
Medpace, Inc.
 Medpace, Inc. Miscellaneous Commercial ServicesCommercial Services Medpace, Inc. provides clinical research services to the pharmaceutical, biotech and medical industries. It offers clinical operations, medical writing, biometrics, regulatory affairs, quality assurance, imaging core lab medical device and risk based monitoring services. The company was founded by August James Troendle in July 1992 and is headquartered in Cincinnati, OH. | Miscellaneous Commercial Services | Chief Executive Officer Director/Board Member | |
| Dartmouth College | College/University | Masters Business Admin Undergraduate Degree | |
| University of Toronto | College/University | Undergraduate Degree Graduate Degree | |
Epic Data International, Inc.
 Epic Data International, Inc. Information Technology ServicesTechnology Services Epic Data International, Inc. manufactures operations management and warehouse management solutions. The firm provides installation and post sales support to the aerospace, defense, automotive, high technology and heavy industrial equipment manufacturers in North America and Western Europe. It develops transaction software and hardware interfaces between custom and enterprise resource planning systems and electronic data capture systems. The company was founded by Helmut Eppich in 1975 and is headquartered in Richmond, Canada. | Information Technology Services | Sales & Marketing Director of Finance/CFO | |
viDA Therapeutics, Inc.
 viDA Therapeutics, Inc. BiotechnologyHealth Technology viDA Therapeutics, Inc. operates as a biotechnology company. It offers discovery, development and commercialization of novel and targeted therapeutics for the treatment of inflammatory and age related diseases. The firm's discovery platform is based on novel research regarding a distinctly different and recently identified, extracellular role for granzymes in the destruction and inflammation of tissues. The company was founded by Alistair Duncan Jr. and David Granville in 2008 and is headquartered in Vancouver, Canada. | Biotechnology | Director/Board Member Founder | |
enGene, Inc.
 enGene, Inc. BiotechnologyHealth Technology enGene, Inc. develops therapeutic solutions for the treatment of metabolic diseases. It operates as a biotechnology company which develops a mucosal immunotherapy platform for treating several prevalent, chronic diseases including inflammatory bowel disease and diabetes. The firm also develops proprietary, non-integrating biopolymer based nucleotide DNA and siRNA delivery technology that facilitates localized delivery of immune-modulating proteins to the intestinal mucosa for treating various immune disorders. The company was founded in 1999 by Anthony T. Cheung, John C. Brown, Timothy J. Kieffer, and Francis John Gargiulo and is headquartered in Vancouver, Canada. | Biotechnology | Chairman Chief Executive Officer | |
Zymeworks BC, Inc.
 Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada. | Biotechnology | Chief Executive Officer Corporate Officer/Principal | |
California Biomedical Innovation Alliance
 California Biomedical Innovation Alliance BiotechnologyHealth Technology California Biomedical Innovation Alliance provides biomedical advocacy and community services. The private company is based in South San Francisco, CA and has subsidiaries in United States. The CEO of the company is Sara Radcliffe. | Biotechnology | Director/Board Member Chairman | |
| Boston University | College/University | Undergraduate Degree Masters Business Admin | |
| University of California, Berkeley | College/University | Undergraduate Degree Masters Business Admin | |
Sandoz, Inc.
 Sandoz, Inc. Pharmaceuticals: MajorHealth Technology Sandoz, Inc. develops, manufactures and distributes generic pharmaceutical products. The firm focuses on therapeutic drug categories such as anti-infective, central nervous system disorder treatments, cardiovascular medicines, gastrointestinal agent, oncology therapies, and respiratory therapies. The company was founded in 1946 and is headquartered in Princeton, NJ. | Pharmaceuticals: Major | Chief Operating Officer Corporate Officer/Principal | |
Mati Therapeutics, Inc.
 Mati Therapeutics, Inc. BiotechnologyHealth Technology Mati Therapeutics, Inc. operates as biotechnology company. It develops non-invasive sustained drug delivery platform to treat ocular diseases, in particular glaucoma. The company was founded by Robert Lee Butchofsky and Christopher A. Muller and is headquartered in Austin, TX. | Biotechnology | Founder Director of Finance/CFO | |
| Purdue University | College/University | Undergraduate Degree | |
| RELYPSA INC | Pharmaceuticals: Major | Director/Board Member | |
| PACIRA BIOSCIENCES, INC. | Pharmaceuticals: Major | Chairman | |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Biotechnology | Corporate Officer/Principal | |
LXR Biotechnology, Inc.
 LXR Biotechnology, Inc. BiotechnologyHealth Technology LXR Biotechnology, Inc. engages in research and development of therapeutics to treat diseases. The private company is based in Richmond, CA. The company was founded by Scott Minick. | Biotechnology | Chief Executive Officer | |
| University of Rhode Island | College/University | Undergraduate Degree | |
ViaCell, Inc.
 ViaCell, Inc. Medical SpecialtiesHealth Technology ViaCell, Inc. provides and develops cellular medicine for the treatment of diseases. The firm develops medicines for treatment of cancer, genetic disorders, organ transplant tolerance, neurological disorders, and autoimmune diseases. The company was founded in April 2000 and is headquartered in Cambridge, MA. | Medical Specialties | Director/Board Member | |
| NKARTA, INC. | Biotechnology | Chief Executive Officer |
Statistieken
Internationaal
| Verenigde Staten | 36 |
| Canada | 16 |
Sectoraal
| Health Technology | 36 |
| Consumer Services | 9 |
| Commercial Services | 6 |
| Technology Services | 2 |
Operationeel
| Director/Board Member | 214 |
| Corporate Officer/Principal | 102 |
| Chairman | 70 |
| Independent Dir/Board Member | 53 |
| Chief Executive Officer | 44 |
Sterkste connecties
| Insiders | |
|---|---|
| Alan C. Mendelson | 45 |
| D. McDonnell | 37 |
| Philip B. Livingston | 31 |
| Ken Galbraith | 30 |
| Paul Hastings | 25 |
| Bruce Carter | 25 |
| Julia G. Levy | 22 |
| Mohammad Azab | 21 |
| Richard R. Vietor | 17 |
| John McLernon | 17 |
| Ron D. Henriksen | 17 |
| August Troendle | 16 |
| Sandra Rose MacKay | 15 |
| C. Boyd Clarke | 15 |
| William Newell | 13 |
- Beurs
- Insiders
- Wajida Leclerc
- Bedrijfsconnecties
